0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oxaliplatin Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-5N9258
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Oxaliplatin Market Insights and Forecast to 2028

Global Oxaliplatin Market Insights and Forecast to 2028

Code: QYRE-Auto-5N9258
Report
January 2022
126 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.
In this report, only the finished drug is covered, exclude API.
Market Analysis and Insights: Global Oxaliplatin Market

The global Oxaliplatin market size is projected to reach US$ 1641.5 million by 2028, from US$ 897.5 million in 2021, at a CAGR of 8.9% during 2022-2028.

Europe is the largest market with about 33% market share. Followed by Japan, accounting for about 30% revenue market share.
The key players are Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira, Mylan, Jiangsu Hengrui Medicine, Nanjing Pharmaceutical Factory, Jiangsu Aosaikang Pharmaceutical, Qilu Pharmaceutical, Hisun Pharmaceutical, Lunan Pharmaceutical, Luoxin, Halfsky Pharmacy, YRPG, Hainan Jinrui Pharmaceutical, Jari Pharmaceutical, Chiatai Tianqing etc. Top 3 companies occupied about 66% revenue market share.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oxaliplatin market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oxaliplatin market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oxaliplatin market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oxaliplatin market.
Global Oxaliplatin Scope and Market Size
Oxaliplatin market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Oxaliplatin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Mannitol
Glucose Solution
Lactose Solution
Others

Segment by Application

Colorectal Cancer
Stomach Cancer
Ovarian Cancer
Others

BY COMPANY

Sanofi-Aventis
Yakult honsha
Dr Reddy's laboratories
Sun Pharmaceutical
Teva
Fresenius Kabi
Hospira
Mylan
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Jiangsu Aosaikang Pharmaceutical
Qilu Pharmaceutical
Hisun Pharmaceutical
Lunan Pharmaceutical
Luoxin
Halfsky Pharmacy
YRPG
Hainan Jinrui Pharmaceutical
Jari Pharmaceutical
Chiatai Tianqing

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oxaliplatin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Mannitol
1.2.3 Glucose Solution
1.2.4 Lactose Solution
1.2.5 Others
1.3 Market by Application
1.3.1 Global Oxaliplatin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Colorectal Cancer
1.3.3 Stomach Cancer
1.3.4 Ovarian Cancer
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oxaliplatin Market Perspective (2017-2028)
2.2 Oxaliplatin Growth Trends by Region
2.2.1 Oxaliplatin Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Oxaliplatin Historic Market Size by Region (2017-2022)
2.2.3 Oxaliplatin Forecasted Market Size by Region (2023-2028)
2.3 Oxaliplatin Market Dynamics
2.3.1 Oxaliplatin Industry Trends
2.3.2 Oxaliplatin Market Drivers
2.3.3 Oxaliplatin Market Challenges
2.3.4 Oxaliplatin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oxaliplatin Players by Revenue
3.1.1 Global Top Oxaliplatin Players by Revenue (2017-2022)
3.1.2 Global Oxaliplatin Revenue Market Share by Players (2017-2022)
3.2 Global Oxaliplatin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oxaliplatin Revenue
3.4 Global Oxaliplatin Market Concentration Ratio
3.4.1 Global Oxaliplatin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oxaliplatin Revenue in 2021
3.5 Oxaliplatin Key Players Head office and Area Served
3.6 Key Players Oxaliplatin Product Solution and Service
3.7 Date of Enter into Oxaliplatin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oxaliplatin Breakdown Data by Type
4.1 Global Oxaliplatin Historic Market Size by Type (2017-2022)
4.2 Global Oxaliplatin Forecasted Market Size by Type (2023-2028)
5 Oxaliplatin Breakdown Data by Application
5.1 Global Oxaliplatin Historic Market Size by Application (2017-2022)
5.2 Global Oxaliplatin Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Oxaliplatin Market Size (2017-2028)
6.2 North America Oxaliplatin Market Size by Type
6.2.1 North America Oxaliplatin Market Size by Type (2017-2022)
6.2.2 North America Oxaliplatin Market Size by Type (2023-2028)
6.2.3 North America Oxaliplatin Market Share by Type (2017-2028)
6.3 North America Oxaliplatin Market Size by Application
6.3.1 North America Oxaliplatin Market Size by Application (2017-2022)
6.3.2 North America Oxaliplatin Market Size by Application (2023-2028)
6.3.3 North America Oxaliplatin Market Share by Application (2017-2028)
6.4 North America Oxaliplatin Market Size by Country
6.4.1 North America Oxaliplatin Market Size by Country (2017-2022)
6.4.2 North America Oxaliplatin Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Oxaliplatin Market Size (2017-2028)
7.2 Europe Oxaliplatin Market Size by Type
7.2.1 Europe Oxaliplatin Market Size by Type (2017-2022)
7.2.2 Europe Oxaliplatin Market Size by Type (2023-2028)
7.2.3 Europe Oxaliplatin Market Share by Type (2017-2028)
7.3 Europe Oxaliplatin Market Size by Application
7.3.1 Europe Oxaliplatin Market Size by Application (2017-2022)
7.3.2 Europe Oxaliplatin Market Size by Application (2023-2028)
7.3.3 Europe Oxaliplatin Market Share by Application (2017-2028)
7.4 Europe Oxaliplatin Market Size by Country
7.4.1 Europe Oxaliplatin Market Size by Country (2017-2022)
7.4.2 Europe Oxaliplatin Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oxaliplatin Market Size (2017-2028)
8.2 Asia-Pacific Oxaliplatin Market Size by Type
8.2.1 Asia-Pacific Oxaliplatin Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Oxaliplatin Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Oxaliplatin Market Share by Type (2017-2028)
8.3 Asia-Pacific Oxaliplatin Market Size by Application
8.3.1 Asia-Pacific Oxaliplatin Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Oxaliplatin Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Oxaliplatin Market Share by Application (2017-2028)
8.4 Asia-Pacific Oxaliplatin Market Size by Region
8.4.1 Asia-Pacific Oxaliplatin Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Oxaliplatin Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Oxaliplatin Market Size (2017-2028)
9.2 Latin America Oxaliplatin Market Size by Type
9.2.1 Latin America Oxaliplatin Market Size by Type (2017-2022)
9.2.2 Latin America Oxaliplatin Market Size by Type (2023-2028)
9.2.3 Latin America Oxaliplatin Market Share by Type (2017-2028)
9.3 Latin America Oxaliplatin Market Size by Application
9.3.1 Latin America Oxaliplatin Market Size by Application (2017-2022)
9.3.2 Latin America Oxaliplatin Market Size by Application (2023-2028)
9.3.3 Latin America Oxaliplatin Market Share by Application (2017-2028)
9.4 Latin America Oxaliplatin Market Size by Country
9.4.1 Latin America Oxaliplatin Market Size by Country (2017-2022)
9.4.2 Latin America Oxaliplatin Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oxaliplatin Market Size (2017-2028)
10.2 Middle East & Africa Oxaliplatin Market Size by Type
10.2.1 Middle East & Africa Oxaliplatin Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Oxaliplatin Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Oxaliplatin Market Share by Type (2017-2028)
10.3 Middle East & Africa Oxaliplatin Market Size by Application
10.3.1 Middle East & Africa Oxaliplatin Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Oxaliplatin Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Oxaliplatin Market Share by Application (2017-2028)
10.4 Middle East & Africa Oxaliplatin Market Size by Country
10.4.1 Middle East & Africa Oxaliplatin Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Oxaliplatin Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi-Aventis
11.1.1 Sanofi-Aventis Company Details
11.1.2 Sanofi-Aventis Business Overview
11.1.3 Sanofi-Aventis Oxaliplatin Introduction
11.1.4 Sanofi-Aventis Revenue in Oxaliplatin Business (2017-2022)
11.1.5 Sanofi-Aventis Recent Developments
11.2 Yakult honsha
11.2.1 Yakult honsha Company Details
11.2.2 Yakult honsha Business Overview
11.2.3 Yakult honsha Oxaliplatin Introduction
11.2.4 Yakult honsha Revenue in Oxaliplatin Business (2017-2022)
11.2.5 Yakult honsha Recent Developments
11.3 Dr Reddy's laboratories
11.3.1 Dr Reddy's laboratories Company Details
11.3.2 Dr Reddy's laboratories Business Overview
11.3.3 Dr Reddy's laboratories Oxaliplatin Introduction
11.3.4 Dr Reddy's laboratories Revenue in Oxaliplatin Business (2017-2022)
11.3.5 Dr Reddy's laboratories Recent Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Details
11.4.2 Sun Pharmaceutical Business Overview
11.4.3 Sun Pharmaceutical Oxaliplatin Introduction
11.4.4 Sun Pharmaceutical Revenue in Oxaliplatin Business (2017-2022)
11.4.5 Sun Pharmaceutical Recent Developments
11.5 Teva
11.5.1 Teva Company Details
11.5.2 Teva Business Overview
11.5.3 Teva Oxaliplatin Introduction
11.5.4 Teva Revenue in Oxaliplatin Business (2017-2022)
11.5.5 Teva Recent Developments
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Details
11.6.2 Fresenius Kabi Business Overview
11.6.3 Fresenius Kabi Oxaliplatin Introduction
11.6.4 Fresenius Kabi Revenue in Oxaliplatin Business (2017-2022)
11.6.5 Fresenius Kabi Recent Developments
11.7 Hospira
11.7.1 Hospira Company Details
11.7.2 Hospira Business Overview
11.7.3 Hospira Oxaliplatin Introduction
11.7.4 Hospira Revenue in Oxaliplatin Business (2017-2022)
11.7.5 Hospira Recent Developments
11.8 Mylan
11.8.1 Mylan Company Details
11.8.2 Mylan Business Overview
11.8.3 Mylan Oxaliplatin Introduction
11.8.4 Mylan Revenue in Oxaliplatin Business (2017-2022)
11.8.5 Mylan Recent Developments
11.9 Jiangsu Hengrui Medicine
11.9.1 Jiangsu Hengrui Medicine Company Details
11.9.2 Jiangsu Hengrui Medicine Business Overview
11.9.3 Jiangsu Hengrui Medicine Oxaliplatin Introduction
11.9.4 Jiangsu Hengrui Medicine Revenue in Oxaliplatin Business (2017-2022)
11.9.5 Jiangsu Hengrui Medicine Recent Developments
11.10 Nanjing Pharmaceutical Factory
11.10.1 Nanjing Pharmaceutical Factory Company Details
11.10.2 Nanjing Pharmaceutical Factory Business Overview
11.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Introduction
11.10.4 Nanjing Pharmaceutical Factory Revenue in Oxaliplatin Business (2017-2022)
11.10.5 Nanjing Pharmaceutical Factory Recent Developments
11.11 Jiangsu Aosaikang Pharmaceutical
11.11.1 Jiangsu Aosaikang Pharmaceutical Company Details
11.11.2 Jiangsu Aosaikang Pharmaceutical Business Overview
11.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Introduction
11.11.4 Jiangsu Aosaikang Pharmaceutical Revenue in Oxaliplatin Business (2017-2022)
11.11.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
11.12 Qilu Pharmaceutical
11.12.1 Qilu Pharmaceutical Company Details
11.12.2 Qilu Pharmaceutical Business Overview
11.12.3 Qilu Pharmaceutical Oxaliplatin Introduction
11.12.4 Qilu Pharmaceutical Revenue in Oxaliplatin Business (2017-2022)
11.12.5 Qilu Pharmaceutical Recent Developments
11.13 Hisun Pharmaceutical
11.13.1 Hisun Pharmaceutical Company Details
11.13.2 Hisun Pharmaceutical Business Overview
11.13.3 Hisun Pharmaceutical Oxaliplatin Introduction
11.13.4 Hisun Pharmaceutical Revenue in Oxaliplatin Business (2017-2022)
11.13.5 Hisun Pharmaceutical Recent Developments
11.14 Lunan Pharmaceutical
11.14.1 Lunan Pharmaceutical Company Details
11.14.2 Lunan Pharmaceutical Business Overview
11.14.3 Lunan Pharmaceutical Oxaliplatin Introduction
11.14.4 Lunan Pharmaceutical Revenue in Oxaliplatin Business (2017-2022)
11.14.5 Lunan Pharmaceutical Recent Developments
11.15 Luoxin
11.15.1 Luoxin Company Details
11.15.2 Luoxin Business Overview
11.15.3 Luoxin Oxaliplatin Introduction
11.15.4 Luoxin Revenue in Oxaliplatin Business (2017-2022)
11.15.5 Luoxin Recent Developments
11.16 Halfsky Pharmacy
11.16.1 Halfsky Pharmacy Company Details
11.16.2 Halfsky Pharmacy Business Overview
11.16.3 Halfsky Pharmacy Oxaliplatin Introduction
11.16.4 Halfsky Pharmacy Revenue in Oxaliplatin Business (2017-2022)
11.16.5 Halfsky Pharmacy Recent Developments
11.17 YRPG
11.17.1 YRPG Company Details
11.17.2 YRPG Business Overview
11.17.3 YRPG Oxaliplatin Introduction
11.17.4 YRPG Revenue in Oxaliplatin Business (2017-2022)
11.17.5 YRPG Recent Developments
11.18 Hainan Jinrui Pharmaceutical
11.18.1 Hainan Jinrui Pharmaceutical Company Details
11.18.2 Hainan Jinrui Pharmaceutical Business Overview
11.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Introduction
11.18.4 Hainan Jinrui Pharmaceutical Revenue in Oxaliplatin Business (2017-2022)
11.18.5 Hainan Jinrui Pharmaceutical Recent Developments
11.19 Jari Pharmaceutical
11.19.1 Jari Pharmaceutical Company Details
11.19.2 Jari Pharmaceutical Business Overview
11.19.3 Jari Pharmaceutical Oxaliplatin Introduction
11.19.4 Jari Pharmaceutical Revenue in Oxaliplatin Business (2017-2022)
11.19.5 Jari Pharmaceutical Recent Developments
11.20 Chiatai Tianqing
11.20.1 Chiatai Tianqing Company Details
11.20.2 Chiatai Tianqing Business Overview
11.20.3 Chiatai Tianqing Oxaliplatin Introduction
11.20.4 Chiatai Tianqing Revenue in Oxaliplatin Business (2017-2022)
11.20.5 Chiatai Tianqing Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global Oxaliplatin Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Mannitol
    Table 3. Key Players of Glucose Solution
    Table 4. Key Players of Lactose Solution
    Table 5. Key Players of Others
    Table 6. Global Oxaliplatin Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Oxaliplatin Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Oxaliplatin Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Oxaliplatin Market Share by Region (2017-2022)
    Table 10. Global Oxaliplatin Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Oxaliplatin Market Share by Region (2023-2028)
    Table 12. Oxaliplatin Market Trends
    Table 13. Oxaliplatin Market Drivers
    Table 14. Oxaliplatin Market Challenges
    Table 15. Oxaliplatin Market Restraints
    Table 16. Global Oxaliplatin Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Oxaliplatin Revenue Share by Players (2017-2022)
    Table 18. Global Top Oxaliplatin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxaliplatin as of 2021)
    Table 19. Ranking of Global Top Oxaliplatin Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Oxaliplatin Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Oxaliplatin Product Solution and Service
    Table 23. Date of Enter into Oxaliplatin Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Oxaliplatin Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Oxaliplatin Revenue Market Share by Type (2017-2022)
    Table 27. Global Oxaliplatin Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Oxaliplatin Revenue Market Share by Type (2023-2028)
    Table 29. Global Oxaliplatin Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Oxaliplatin Revenue Share by Application (2017-2022)
    Table 31. Global Oxaliplatin Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Oxaliplatin Revenue Share by Application (2023-2028)
    Table 33. North America Oxaliplatin Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Oxaliplatin Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Oxaliplatin Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Oxaliplatin Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Oxaliplatin Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Oxaliplatin Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Oxaliplatin Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Oxaliplatin Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Oxaliplatin Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Oxaliplatin Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Oxaliplatin Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Oxaliplatin Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Oxaliplatin Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Oxaliplatin Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Oxaliplatin Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Oxaliplatin Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Oxaliplatin Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Oxaliplatin Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Oxaliplatin Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Oxaliplatin Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Oxaliplatin Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Oxaliplatin Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Oxaliplatin Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Oxaliplatin Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Oxaliplatin Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Oxaliplatin Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Oxaliplatin Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Oxaliplatin Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Oxaliplatin Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Oxaliplatin Market Size by Country (2023-2028) & (US$ Million)
    Table 63. Sanofi-Aventis Company Details
    Table 64. Sanofi-Aventis Business Overview
    Table 65. Sanofi-Aventis Oxaliplatin Product
    Table 66. Sanofi-Aventis Revenue in Oxaliplatin Business (2017-2022) & (US$ Million)
    Table 67. Sanofi-Aventis Recent Developments
    Table 68. Yakult honsha Company Details
    Table 69. Yakult honsha Business Overview
    Table 70. Yakult honsha Oxaliplatin Product
    Table 71. Yakult honsha Revenue in Oxaliplatin Business (2017-2022) & (US$ Million)
    Table 72. Yakult honsha Recent Developments
    Table 73. Dr Reddy's laboratories Company Details
    Table 74. Dr Reddy's laboratories Business Overview
    Table 75. Dr Reddy's laboratories Oxaliplatin Product
    Table 76. Dr Reddy's laboratories Revenue in Oxaliplatin Business (2017-2022) & (US$ Million)
    Table 77. Dr Reddy's laboratories Recent Developments
    Table 78. Sun Pharmaceutical Company Details
    Table 79. Sun Pharmaceutical Business Overview
    Table 80. Sun Pharmaceutical Oxaliplatin Product
    Table 81. Sun Pharmaceutical Revenue in Oxaliplatin Business (2017-2022) & (US$ Million)
    Table 82. Sun Pharmaceutical Recent Developments
    Table 83. Teva Company Details
    Table 84. Teva Business Overview
    Table 85. Teva Oxaliplatin Product
    Table 86. Teva Revenue in Oxaliplatin Business (2017-2022) & (US$ Million)
    Table 87. Teva Recent Developments
    Table 88. Fresenius Kabi Company Details
    Table 89. Fresenius Kabi Business Overview
    Table 90. Fresenius Kabi Oxaliplatin Product
    Table 91. Fresenius Kabi Revenue in Oxaliplatin Business (2017-2022) & (US$ Million)
    Table 92. Fresenius Kabi Recent Developments
    Table 93. Hospira Company Details
    Table 94. Hospira Business Overview
    Table 95. Hospira Oxaliplatin Product
    Table 96. Hospira Revenue in Oxaliplatin Business (2017-2022) & (US$ Million)
    Table 97. Hospira Recent Developments
    Table 98. Mylan Company Details
    Table 99. Mylan Business Overview
    Table 100. Mylan Oxaliplatin Product
    Table 101. Mylan Revenue in Oxaliplatin Business (2017-2022) & (US$ Million)
    Table 102. Mylan Recent Developments
    Table 103. Jiangsu Hengrui Medicine Company Details
    Table 104. Jiangsu Hengrui Medicine Business Overview
    Table 105. Jiangsu Hengrui Medicine Oxaliplatin Product
    Table 106. Jiangsu Hengrui Medicine Revenue in Oxaliplatin Business (2017-2022) & (US$ Million)
    Table 107. Jiangsu Hengrui Medicine Recent Developments
    Table 108. Nanjing Pharmaceutical Factory Company Details
    Table 109. Nanjing Pharmaceutical Factory Business Overview
    Table 110. Nanjing Pharmaceutical Factory Oxaliplatin Product
    Table 111. Nanjing Pharmaceutical Factory Revenue in Oxaliplatin Business (2017-2022) & (US$ Million)
    Table 112. Nanjing Pharmaceutical Factory Recent Developments
    Table 113. Jiangsu Aosaikang Pharmaceutical Company Details
    Table 114. Jiangsu Aosaikang Pharmaceutical Business Overview
    Table 115. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Product
    Table 116. Jiangsu Aosaikang Pharmaceutical Revenue in Oxaliplatin Business (2017-2022) & (US$ Million)
    Table 117. Jiangsu Aosaikang Pharmaceutical Recent Developments
    Table 118. Qilu Pharmaceutical Company Details
    Table 119. Qilu Pharmaceutical Business Overview
    Table 120. Qilu Pharmaceutical Oxaliplatin Product
    Table 121. Qilu Pharmaceutical Revenue in Oxaliplatin Business (2017-2022) & (US$ Million)
    Table 122. Qilu Pharmaceutical Recent Developments
    Table 123. Hisun Pharmaceutical Company Details
    Table 124. Hisun Pharmaceutical Business Overview
    Table 125. Hisun Pharmaceutical Oxaliplatin Product
    Table 126. Hisun Pharmaceutical Revenue in Oxaliplatin Business (2017-2022) & (US$ Million)
    Table 127. Hisun Pharmaceutical Recent Developments
    Table 128. Lunan Pharmaceutical Company Details
    Table 129. Lunan Pharmaceutical Business Overview
    Table 130. Lunan Pharmaceutical Oxaliplatin Product
    Table 131. Lunan Pharmaceutical Revenue in Oxaliplatin Business (2017-2022) & (US$ Million)
    Table 132. Lunan Pharmaceutical Recent Developments
    Table 133. Luoxin Company Details
    Table 134. Luoxin Business Overview
    Table 135. Luoxin Oxaliplatin Product
    Table 136. Luoxin Revenue in Oxaliplatin Business (2017-2022) & (US$ Million)
    Table 137. Luoxin Recent Developments
    Table 138. Halfsky Pharmacy Company Details
    Table 139. Halfsky Pharmacy Business Overview
    Table 140. Halfsky Pharmacy Oxaliplatin Product
    Table 141. Halfsky Pharmacy Revenue in Oxaliplatin Business (2017-2022) & (US$ Million)
    Table 142. Halfsky Pharmacy Recent Developments
    Table 143. YRPG Company Details
    Table 144. YRPG Business Overview
    Table 145. YRPG Oxaliplatin Product
    Table 146. YRPG Revenue in Oxaliplatin Business (2017-2022) & (US$ Million)
    Table 147. YRPG Recent Developments
    Table 148. Hainan Jinrui Pharmaceutical Company Details
    Table 149. Hainan Jinrui Pharmaceutical Business Overview
    Table 150. Hainan Jinrui Pharmaceutical Oxaliplatin Product
    Table 151. Hainan Jinrui Pharmaceutical Revenue in Oxaliplatin Business (2017-2022) & (US$ Million)
    Table 152. Hainan Jinrui Pharmaceutical Recent Developments
    Table 153. Jari Pharmaceutical Company Details
    Table 154. Jari Pharmaceutical Business Overview
    Table 155. Jari Pharmaceutical Oxaliplatin Product
    Table 156. Jari Pharmaceutical Revenue in Oxaliplatin Business (2017-2022) & (US$ Million)
    Table 157. Jari Pharmaceutical Recent Developments
    Table 158. Chiatai Tianqing Company Details
    Table 159. Chiatai Tianqing Business Overview
    Table 160. Chiatai Tianqing Oxaliplatin Product
    Table 161. Chiatai Tianqing Revenue in Oxaliplatin Business (2017-2022) & (US$ Million)
    Table 162. Chiatai Tianqing Recent Developments
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Oxaliplatin Market Share by Type: 2021 VS 2028
    Figure 2. Mannitol Features
    Figure 3. Glucose Solution Features
    Figure 4. Lactose Solution Features
    Figure 5. Others Features
    Figure 6. Global Oxaliplatin Market Share by Application: 2021 VS 2028
    Figure 7. Colorectal Cancer Case Studies
    Figure 8. Stomach Cancer Case Studies
    Figure 9. Ovarian Cancer Case Studies
    Figure 10. Others Case Studies
    Figure 11. Oxaliplatin Report Years Considered
    Figure 12. Global Oxaliplatin Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Oxaliplatin Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Oxaliplatin Market Share by Region: 2021 VS 2028
    Figure 15. Global Oxaliplatin Market Share by Players in 2021
    Figure 16. Global Top Oxaliplatin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxaliplatin as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Oxaliplatin Revenue in 2021
    Figure 18. North America Oxaliplatin Market Size YoY (2017-2028) & (US$ Million)
    Figure 19. North America Oxaliplatin Market Size Market Share by Type (2017-2028)
    Figure 20. North America Oxaliplatin Market Size Market Share by Application (2017-2028)
    Figure 21. North America Oxaliplatin Market Size Share by Country (2017-2028)
    Figure 22. United States Oxaliplatin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Oxaliplatin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Oxaliplatin Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. Europe Oxaliplatin Market Size Market Share by Type (2017-2028)
    Figure 26. Europe Oxaliplatin Market Size Market Share by Application (2017-2028)
    Figure 27. Europe Oxaliplatin Market Size Share by Country (2017-2028)
    Figure 28. Germany Oxaliplatin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France Oxaliplatin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. Oxaliplatin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy Oxaliplatin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia Oxaliplatin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries Oxaliplatin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Oxaliplatin Market Size YoY (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific Oxaliplatin Market Size Market Share by Type (2017-2028)
    Figure 36. Asia Pacific Oxaliplatin Market Size Market Share by Application (2017-2028)
    Figure 37. Asia Pacific Oxaliplatin Market Size Share by Region (2017-2028)
    Figure 38. China Oxaliplatin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Japan Oxaliplatin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. South Korea Oxaliplatin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Southeast Asia Oxaliplatin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. India Oxaliplatin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Australia Oxaliplatin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Latin America Oxaliplatin Market Size YoY (2017-2028) & (US$ Million)
    Figure 45. Latin America Oxaliplatin Market Size Market Share by Type (2017-2028)
    Figure 46. Latin America Oxaliplatin Market Size Market Share by Application (2017-2028)
    Figure 47. Latin America Oxaliplatin Market Size Share by Country (2017-2028)
    Figure 48. Mexico Oxaliplatin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Brazil Oxaliplatin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Oxaliplatin Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Middle East and Africa Oxaliplatin Market Size Market Share by Type (2017-2028)
    Figure 52. Middle East and Africa Oxaliplatin Market Size Market Share by Application (2017-2028)
    Figure 53. Middle East and Africa Oxaliplatin Market Size Share by Country (2017-2028)
    Figure 54. Turkey Oxaliplatin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Oxaliplatin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. UAE Oxaliplatin Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Sanofi-Aventis Revenue Growth Rate in Oxaliplatin Business (2017-2022)
    Figure 58. Yakult honsha Revenue Growth Rate in Oxaliplatin Business (2017-2022)
    Figure 59. Dr Reddy's laboratories Revenue Growth Rate in Oxaliplatin Business (2017-2022)
    Figure 60. Sun Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2017-2022)
    Figure 61. Teva Revenue Growth Rate in Oxaliplatin Business (2017-2022)
    Figure 62. Fresenius Kabi Revenue Growth Rate in Oxaliplatin Business (2017-2022)
    Figure 63. Hospira Revenue Growth Rate in Oxaliplatin Business (2017-2022)
    Figure 64. Mylan Revenue Growth Rate in Oxaliplatin Business (2017-2022)
    Figure 65. Jiangsu Hengrui Medicine Revenue Growth Rate in Oxaliplatin Business (2017-2022)
    Figure 66. Nanjing Pharmaceutical Factory Revenue Growth Rate in Oxaliplatin Business (2017-2022)
    Figure 67. Jiangsu Aosaikang Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2017-2022)
    Figure 68. Qilu Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2017-2022)
    Figure 69. Hisun Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2017-2022)
    Figure 70. Lunan Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2017-2022)
    Figure 71. Luoxin Revenue Growth Rate in Oxaliplatin Business (2017-2022)
    Figure 72. Halfsky Pharmacy Revenue Growth Rate in Oxaliplatin Business (2017-2022)
    Figure 73. YRPG Revenue Growth Rate in Oxaliplatin Business (2017-2022)
    Figure 74. Hainan Jinrui Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2017-2022)
    Figure 75. Jari Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2017-2022)
    Figure 76. Chiatai Tianqing Revenue Growth Rate in Oxaliplatin Business (2017-2022)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona

RELATED REPORTS

Global Granisetron Hydrochloride API Market Insights Forecast to 2028
Global Granisetron Hydrochloride API Market Insights, Forecast to 2028

It is a raw material for nervous system and is used in the production of Tropisetron Hydrochloride.Market Analysis and Insights Global Granisetron Hydrochloride API MarketDue to the COVID19 pandemic the global Granisetron Hydrochloride API market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-35O10206
Sun May 22 00:00:00 UTC 2022

Add to Cart

Global Lab Scale Bioreactor Market Insights Forecast to 2028
Global Lab Scale Bioreactor Market Insights, Forecast to 2028

The small volume bioreactors enable the biomass growth extracellular metabolite production solidstate fermentation and biocatalytic processes in a controlled open system.Market Analysis and Insights Global Lab Scale Bioreactor MarketDue to the COVID19 pandemic the global Lab Scale Bioreactor market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-17O10483
Sun May 22 00:00:00 UTC 2022

Add to Cart

Global Ocular Excipients Market Insights Forecast to 2028
Global Ocular Excipients Market Insights, Forecast to 2028

Market Analysis and Insights Global Ocular Excipients MarketDue to the COVID19 pandemic the global Ocular Excipients market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-2T10675
Sun May 22 00:00:00 UTC 2022

Add to Cart

Global Barium Titanium Oxide Market Insights Forecast to 2028
Global Barium Titanium Oxide Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-9Z7409
Wed May 18 00:00:00 UTC 2022

Add to Cart